DENALI THERAPEUTICS INC's ticker is and the CUSIP is 24823R955. A total of 2 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,126 | -76.7% | 200 | -66.7% | 0.00% | – |
| Q2 2023 | $17,706 | -99.0% | 600 | -99.2% | 0.00% | -100.0% |
| Q1 2023 | $1,810,944 | +4665.6% | 78,600 | +5946.2% | 0.01% | – |
| Q2 2022 | $38,000 | -80.9% | 1,300 | -79.0% | 0.00% | – |
| Q1 2022 | $199,000 | -81.9% | 6,200 | -74.9% | 0.00% | -100.0% |
| Q4 2021 | $1,102,000 | +4491.7% | 24,700 | +8133.3% | 0.00% | – |
| Q2 2021 | $24,000 | -42.9% | 300 | -40.0% | 0.00% | – |
| Q4 2020 | $42,000 | -2.3% | 500 | -58.3% | 0.00% | – |
| Q3 2020 | $43,000 | +2050.0% | 1,200 | +1100.0% | 0.00% | – |
| Q2 2020 | $2,000 | -88.2% | 100 | -90.9% | 0.00% | – |
| Q3 2019 | $17,000 | +750.0% | 1,100 | +1000.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 200 | $4,126 | 0.00% |